Hepatitis C

Hepatitis C is a devastating viral disease that generally progresses slowly, meaning patients often remain asymptomatic and unaware they are infected until very serious and often expensive complications emerge as a result of damage to the liver. It is estimated that about half of those infected are not aware that they carry the virus. The recent remarkable advances in treating hepatitis C built on incremental improvements achieved over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and forthcoming treatments, can be potentially cured.

  • Recent Advances in Hepatitis C therapy
  • Prevention of HCV reinfection
  • HCV: Direct Acting Antiviral Era
  • Hepatitis C: Epidemiology
  • HCV Kinetic Models and Implications in Drug Development
  • Treatment options in patients who failed DAA regimens

Related Conference of Hepatitis C

December 08-09, 2016

International Conference on Digestive Diseases

Dubai, UAE
April 27-28, 2017

4th International Conference on Hepatology

Dubai, UAE
June 12-13, 2017

11th Annual
Gastroenterologists Meeting

Rome, Italy
August 10-12, 2017

5th World Congress on Hepatitis & Liver Diseases

London, UK
September 11-12, 2017

12th Euro-Global Gastroenterology Conference

Paris, France
October 16-18, 2017

2nd World Summit on Metabolic Disorders

Chicago, Illinois, USA
October 30- November 01, 2017

10th International Conference on Gastroenterology

Bangkok, Thailand

Hepatitis C Conference Speakers

Recommended Sessions

Related Journals

Are you interested in